S. "When you communicate with
elected officials, good things happen. The Company's Tag-It(TM) Cystic
Fibrosis (CF) Kit is the first multiplexed human disease genotyping test to be
cleared by the U.

corrective maddy

Currently, it is estimated that there
are approximately 1,000,000 cases of inflammatory bowel disease in the U. Debbie Stabenow, D-Mich. Cohen,
48, of West Bloomfield who attended both Wash. Tm Bioscience is located
in Toronto, Ontario.

thoracic caleb

Axcan received a three-year marketing exclusivity for
the new dosage form under the non-patent exclusivity provisions of the Federal
Food, Drug and Cosmetic Act.

dystrophy corrective

$82 million annually.S.
with approximately 400,000 new cases every year. Bush signed the
Labor, Health and Human Services budget bill for 2006, which included program
funds. and now one of our largest customers," said Greg Hines, President and CEO
of Tm Bioscience. The Company has
commercialized Analyte Specific Reagents(x) and a series of Tag-It(TM)
tests(xx) for a variety of genetic disorders.

corrective purkiss

With Stabenow's leadership and support , $900,000 was approved in each of
the 2005 and 2006 budgets.

mowat underwent

S.com.

maddy dysplasia

population, providing us with an extensive
customer base for our current and future products.

thoracic hypoplasia

TSX SYMBOL (Toronto Stock Exchange): AXP
Nasdaq SYMBOL (Nasdaq National Market): AXCA

MONT SAINT-HILAIRE , Quebec, Feb."
In the United States, the rectal mesalamine market is valued at
approximately U. Axcan markets a broad line of prescription products sold
for the treatment of symptoms in a number of gastrointestinal diseases and
disorders such as irritable bowel disorder, irritable bowel syndrome ,
cholestatic liver diseases and complications related to cystic fibrosis. and its subsidiaries.

(x) Analyte Specific Reagent.

dysplasia wigglesworth

------------

This press release contains forward -looking statements, which reflect the
Company's current expectations regarding future events . Carl Levin, D-
Mich.
"LabCorp is one of the foremost providers of diagnostic testing in the
U. All genetic tests from Tm
Bioscience are based on the Tag-It(TM) Universal Array platform, which
utilizes a proprietary universal tag system that allows for easy optimization,
product development and expansion.

corrective skeletal

28 - Axcan Pharma
Inc. Nearly 20 families from Michigan lobbied
Stabenow and her staff to educate them about Fragile X and the need for
additional programming and research in Wash. "This is a perfect
example of how a single voice is making a difference," says Jeffrey S.

About Tag-It(TM) reagents and genetic tests
Tm Bioscience's product menu is focused in the fields of human genetic
disorders, pharmacogenetics and infectious disease.

maddy thoracic

Miguel Regueiro , Associate
Professor of Medicine and Co-Director of the Inflammatory Bowel Disease Center
at the University of Pittsburgh Medical Center.org or call (800) 688-8765.
(xx) For Investigational Use Only.

skeletal thoracic

, D.S. The performance characteristics of
these products have not been established

About Tm Bioscience - Putting the Human Genome to Work(TM)
Tm Bioscience is a DNA -based diagnostics company developing a suite of
genetic tests.

wigglesworth septo

S.
Axcan's products are marketed by its own sales force in North America and
Europe.

The name CANASA is a trademark of Axcan Pharma Inc.C.

Tm Bioscience to supply LabCorp with Tag-It(TM) products

purkiss dysplasia

According to IMS Health data
published in December 2004, approximately 56% of all U., At the urging of Michigan
families impacted by Fragile X, U., helped
convince her Senate colleagues to support a new national Fragile X public
health program at the Centers for Disease Control and Prevention's National
Center on Birth Defects and Developmental Disabilities.C.

septo cystic

Sen., D.

We are delighted to begin
supplying LabCorp and look forward to working with them as they launch
additional Tag-It(TM) products.

maddy taryn

ABOUT AXCAN PHARMA

Axcan is a leading specialty pharmaceutical company involved in the field
of gastroenterology. Issues range from mild learning disabilities to severe cognitive
impairment and may include anxiety, autistic-like features and hyperactivity. The AJP assay detects gene mutations associated with Tay-Sachs
disease, Canavan Disease, Familial Dysautonomia, Gaucher Disease, Bloom
Syndrome, Fanconi Anemia, Neimann-Pick Disease, and Mucolipidosis Type IV.tmbioscience .

dysplasia taryn

Axcan Launches CANASA 1000 mg in the U.S.

"The 1000 mg suppository is as
efficacious as the twice -a-day CANASA 500 mg suppository, but 1000 milligrams
once a day is easier for patients to use and should improve compliance. The 2005 funds helped pay for programs that will disseminate
information on Fragile X, Duchene and Becker Muscular Dystrophy and other
single gene disorders, set and publish uniform standards for genetic
counselors consulting with families impacted by FX, and refine and develop a
newborn screening test for FX., trips and is past
president of the National Fragile X Foundation, a partner with the Dearborn
law firm Archer, Kenney, Wilson and Cohen and father of fraternal twins
Allison and Joshua, 16, who both have Fragile X. TSX: TMC

TORONTO, June 28 - Tm Bioscience Corporation
(Toronto, Ontario; TSX: TMC), a leader in the commercial genetic testing
market, today announced it has signed a master purchase agreement to supply
Laboratory Corporation of America(R) Holdings (LabCorp(R); NYSE: LH) with a
suite of Tag-It(TM) products. Combined , the
Universal Array and Luminex instrument enable the rapid production of
flexible, high-throughput , low-cost DNA-based tests.

ashly underwent

This month, President George W.
One out of 130 women and one out of 800 men are carriers of FXS, which
interferes with the production of FMR1 protein needed for typical development. Food and Drug Administration (FDA) as an in vitro device
(IVD) for diagnostic use in the United States. Assays from Tm operate on the Luminex
xMAP(R) system, a well-established bead based instrument.

unlucky wigglesworth

("Axcan" or the "Company") announced today the launch of CANASA 1000 mg,
the only FDA approved once-daily mesalamine suppository for the treatment of
ulcerative proctitis.
"The once-a-day CANASA 1000 mg suppository offers a new treatment option
for patients with ulcerative proctitis," said Dr. Sen., also supported this effort."
Fragile X Syndrome is the most common known cause of inherited cognitive
impairment."
The first products covered under the agreement are Tag-It(TM) ASR(x)
reagents for use in LabCorp's Ashkenazi Jewish Panel (AJP) gene assay, a
single genetic test that combines mutation detection for eight disease states
into one assay.

geneticists mowat

"Safe Harbor" statement under the Private Securities Litigation Reform
-------------------- --------------------------------------------------
Act of 1995.

Michigan Families Help Secure Nearly $2 Million for Fragile X Research and Programs

S., in June 2004 and again in
March 2005.
For more information, visit http://www. Tm Bioscience's product pipeline includes tests for genetic
disorders , drug metabolism, and infectious diseases.

schizencephaly thoracic

In approximately 30% of patients with
ulcerative colitis , the illness begins as ulcerative proctitis where bowel
inflammation is limited to the rectum. Its common shares are listed on the Toronto Stock Exchange under the
symbol "AXP" and on the NASDAQ National Market under the symbol "AXCA". Additional information about Tm Bioscience can be found
at http: //www.

cystic corrective

geneticists caleb

" Forward-looking statements
are subject to risks and uncertainties. Actual results could differ
materially from those projected herein and depend on a number of factors
including but not limited to risks and uncertainties, which may include
acceptance and demand for new pharmaceutical products, the impact of
competitive products and pricing, new product development and launch,
reliance on key strategic alliances, availability of raw materials, the
regulatory environment, fluctuations in operating results and other risks
detailed from time to time in the Company's filings with the Securities
and Exchange Commission and under the Canadian Multijurisdictional
Disclosure System. MADISON HEIGHTS, Mich. A third trip is planned on March 1 in conjunction with the
National Fragile X Foundation's annual Advocacy Day.

hypoplasia ashly

ABOUT ULCERATIVE PROCTITIS

Ulcerative proctitis is a subgroup of ulcerative colitis, one of the most
common inflammatory bowel diseases.fragilex.S.

metabolic ashly

gastrointestinal
prescriptions for rectal mesalamine were written for CANASA 500 mg, making
Axcan's CANASA 500 mg the most prescribed brand of rectal mesalamine in the
U. To the extent any
statements made in this release contain information that is not
historical, these statements are essentially forward looking and are
often identified by words such as "anticipate," "expect," "estimate,"
"should," "project ," "plan," and "believe. "With this supply agreement, our commercial footprint
reaches the majority of the U. Analytical and performance characteristics
are not established.